Clinical Trial Update: Interleukin (IL)-13 as a Marker in Pediatrics Asthma

View source ↗

Summary

This completed clinical trial evaluated Interleukin-13 as a biomarker in pediatric asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Rush University Medical Center | Conditions: Asthma | Status: COMPLETED